Article info

Download PDFPDF

Original research
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma

Authors

  1. Correspondence to Prof. Jiejie Xu; jjxufdu{at}fudan.edu.cn; Prof. Weijuan Zhang; weijuanzhang{at}fudan.edu.cn; Dr. Yu Zhu; yuzhu10{at}fudan.edu.cn
View Full Text

Citation

Zhou Q, Qi Y, Wang Z, et al
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma

Publication history

  • Accepted March 31, 2020
  • First published May 5, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.